Embecta

Yahoo Finance • last month

Insulin Delivery Device Company Evaluation Report 2025 | Embecta, Novo Nordisk, and Ypsomed Lead with Innovative Injection and Digital Management Solutions

Company Logo The Insulin Delivery Devices Companies Quadrant presents a detailed analysis of the global insulin delivery devices market, spotlighting the top 25 companies like Embecta Corp, Novo Nordisk, and Ypsomed as quadrant leaders. T... Full story

Yahoo Finance • 2 months ago

embecta to Participate in Investor Events

PARSIPPANY, N.J., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today announced th... Full story

Yahoo Finance • 2 months ago

Mizuho raises Embecta stock price target to $14 on strong Q3 results

Investing.com - Mizuho raised its price target on Embecta (NASDAQ:EMBC) to $14.00 from $12.00 on Monday, while maintaining a Neutral rating on the medical device company’s stock. According to InvestingPro data, the company currently trad... Full story

Yahoo Finance • 2 months ago

Embecta Corp (NASDAQ:EMBC) Surpasses Q3 Earnings Estimates, Shares Jump 10.5% in Pre-Market Trading

Embecta Corp (NASDAQ:EMBC [https://www.chartmill.com/stock/quote/EMBC]) reported its third-quarter fiscal 2025 earnings, surpassing analyst expectations on both revenue and earnings per share (EPS). The company’s performance has triggered... Full story

Yahoo Finance • 2 months ago

Embecta Corp. Reports Third Quarter Fiscal 2025 Financial Results

PARSIPPANY, N.J., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three and nine month periods ended June 30, 2025. "Q... Full story

Yahoo Finance • 2 months ago

embecta Announces Quarterly Cash Dividend

PARSIPPANY, N.J., Aug. 08, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.15 for each issued and outstanding share of the Company’s common stock. T... Full story

Yahoo Finance • 3 months ago

embecta to Report Fiscal Third Quarter 2025 Financial Results

PARSIPPANY, N.J., July 24, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, will host a confer... Full story

Yahoo Finance • 3 months ago

Mizuho Lowers PT on Embecta Corp. (EMBC) to $13 From $15, Keeps a Neutral Rating

Embecta Corp. (NASDAQ:EMBC) is one of the 13 Cheap Healthcare Stocks with Huge Upside Potential. On May 23, Mizuho lowered the firm’s price target on Embecta Corp. (NASDAQ:EMBC) to $13 from $15, keeping a Neutral rating on the shares. The... Full story

Yahoo Finance • 4 months ago

Embecta Corp. (EMBC) Lowered FY25 Guidance Amid Foreign Exchange Challenges

River Road Asset Management, an investment management company, released its “River Road Small Cap Value Fund” Q1 2025 investor letter. A copy of the letter can be downloaded here. In the first quarter, AMG River Road Small Cap Value Fund (... Full story

Yahoo Finance • 5 months ago

embecta to Showcase Phased Approach for Value Creation and Present Long Range Financial Plan at 2025 Analyst and Investor Day

PARSIPPANY, N.J., May 22, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta"; "The Company") (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host its inaugural Analyst and Investor Day today... Full story

Yahoo Finance • 6 months ago

embecta to Report Fiscal Second Quarter 2025 Financial Results

PARSIPPANY, N.J., April 21, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call to discuss its fiscal second quarter 20... Full story

Yahoo Finance • 6 months ago

Mayo Clinic Proceedings Publishes New Global Insulin Injection Recommendations

PARSIPPANY, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, today announced a new landmark publication in the Mayo Clinic Proce... Full story

Yahoo Finance • 8 months ago

embecta to Participate at the J.P. Morgan Global Leveraged Finance Conference

PARSIPPANY, N.J., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that Jake Elguicze, embecta’s Chief Financial Officer, will present at the J.P. Morgan Global Leveraged Finance Conference in Miam... Full story

Yahoo Finance • 8 months ago

Embecta Corp. Reports First Quarter Fiscal 2025 Financial Results

PARSIPPANY, N.J., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three month period ended December 31, 2024. "Buildin... Full story

Yahoo Finance • 9 months ago

embecta to Report Fiscal First Quarter 2025 Financial Results

PARSIPPANY, N.J., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call to discuss its fiscal first quarter 2025... Full story

Yahoo Finance • 2 years ago

16 Most Profitable New Stocks Today

In this article, we will take a detailed look at the16 Most Profitable New Stocks Today. For a quick overview of such stocks, read our article 5 Most Profitable New Stocks Today. IPO activity showed some signs of a rebound in 2023 but pub... Full story

Yahoo Finance • 2 years ago

embecta to Participate in Investor Conferences

PARSIPPANY, N.J., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company, today announced that management will participate in the following investor events: 2023 Mizuho Medical Device... Full story

Yahoo Finance • 2 years ago

Embecta Corp. Reports Fiscal 2023 Fourth Quarter and Full Year Financial Results and Provides Initial Fiscal 2024 Financial Guidance

PARSIPPANY, N.J., Nov. 21, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three- and twelve-month periods ended September 30, 2... Full story

Yahoo Finance • 2 years ago

embecta to Report Fiscal Fourth Quarter and Full Year 2023 Financial Results

PARSIPPANY, N.J., Oct. 25, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company, will host a conference call to discuss its fiscal fourth quarter and full year 2023 financial results, and prov... Full story

Yahoo Finance • 2 years ago

embecta to Participate at the Morgan Stanley 21st Annual Healthcare Conference

PARSIPPANY, N.J., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will participate in a fireside chat at the Morgan Stanley 21st Annual Healthcare Conference in New York on Tuesda... Full story